Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1221 (LINC01221) is a human long non-coding RNA gene, located at chromosome 1q32, that does not encode a protein but regulates gene expression at the transcriptional and post-transcriptional levels. LINC01221 has been identified as significantly overexpressed in pediatric T-cell acute lymphoblastic leukemia (T-ALL), where it may contribute to disease progression through modulation of apoptosis, cell proliferation, metastasis, and cancer survival pathways. LINC01221 and related lncRNAs are being studied for their role in cancer pathogenesis and their potential as biomarkers for diagnosis, prognosis, and disease subtype discrimination in leukemia. Although computational enrichment analyses suggest possible interactions with anticancer therapeutics, no direct drug targeting has yet been validated.
Not a direct drug target; mechanisms of drugs interacting with LINC01221, if any, are currently unknown due to its non-coding RNA nature. Any effects are likely mediated through modulation of gene expression and cellular pathways involved in apoptosis, proliferation, or drug response.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1221 (LINC01221).